Teradyne (TER) Research & Development (2009 - 2026)

Teradyne has reported Research & Development for 18 years, with the latest figure at $156.3 million in Q2 2026.

• Research & Development for Q2 2026 came in at $156.3 million, up 32.02% year-over-year; the trailing twelve-month figure through Jun 2026 was $559.9 million (up 16.05% YoY), and the FY2025 annual result was $504.6 million, up 9.49% from the prior year.
• Research & Development rose to $156.3 million in Q2 2026, from $135.6 million in the prior quarter.
• Over five years, Research & Development peaked at $156.3 million in Q2 2026 and troughed at $102.2 million in Q4 2023.
• A 5-year average of $117.6 million and a median of $111.9 million in 2022 frame the typical range for Research & Development.
• The widest annual swing landed in 2023, when Research & Development declined 6.54%; it then soared 32.02% in 2026.
• A 5-year view of Research & Development shows it stood at $108.8 million in 2022, then decreased by 6.07% to $102.2 million in 2023, then rose by 25.61% to $128.4 million in 2024, then grew by 11.59% to $143.3 million in 2025, then increased by 9.09% to $156.3 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $156.3 million in Q2 2026, $135.6 million in Q1 2026, and $143.3 million in Q4 2025.